We are live on ! Find out more
IART icon

Integra LifeSciences

210 hedge funds and large institutions have $2.67B invested in Integra LifeSciences in 2016 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 80 increasing their positions, 71 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,779% more call options, than puts

Call options by funds: $2.99M | Put options by funds: $104K

113% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 16

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

22% more capital invested

Capital invested by funds: $2.2B → $2.67B (+$473M)

13% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 71

8% more funds holding

Funds holding: 194210 (+16)

Holders
210
Holders Change
+16
Holders Change %
+8.25%
% of All Funds
5.6%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
34
Increased
80
Reduced
71
Closed
16
Calls
$2.99M
Puts
$104K
Net Calls
+$2.89M
Net Calls Change
+$2.68M
Name Holding Trade Value Shares
Change
Change in
Stake
TCM
51
Tributary Capital Management
Nebraska
$11.4M +$1.08M +29,924 +12%
FPC
52
Falcon Point Capital
California
$10.7M +$571K +15,868 +6%
MFIMFI
53
Mesirow Financial Investment Management - Fixed Income
Illinois
$10.4M +$9.34M +259,700 New
BIM
54
BlackRock Investment Management
Delaware
$10M +$706K +19,624 +8%
EIP
55
Epoch Investment Partners
New York
$9.9M -$20M -556,460 -69%
CM
56
Castleark Management
Illinois
$8.87M +$8M +222,300 New
IAM
57
Impax Asset Management
New Hampshire
$8.4M
American Century Companies
58
American Century Companies
Missouri
$8.37M -$1.01M -28,156 -12%
Renaissance Technologies
59
Renaissance Technologies
New York
$8.18M +$4.98M +138,400 +208%
GH
60
GAM Holding
Switzerland
$7.95M +$7.17M +199,200 New
NAM
61
Netols Asset Management
Wisconsin
$7.7M -$1.72M -47,762 -20%
Axa
62
Axa
France
$7.68M +$2.89M +80,368 +72%
TCIM
63
TIAA CREF Investment Management
New York
$7.62M -$2.2M -61,222 -24%
California Public Employees Retirement System
64
California Public Employees Retirement System
California
$6.8M -$108K -3,000 -2%
Millennium Management
65
Millennium Management
New York
$6.78M -$15.5M -429,668 -72%
FIM
66
Foresters Investment Management
New York
$6.66M +$576K +16,000 +11%
Bank of America
67
Bank of America
North Carolina
$6.13M +$371K +10,304 +7%
EAM
68
Eagle Asset Management
Florida
$5.87M +$183K +5,084 +4%
Prudential Financial
69
Prudential Financial
New Jersey
$5.67M -$34.5K -960 -0.7%
GLA
70
Great Lakes Advisors
Illinois
$5.49M +$58.5K +1,626 +1%
ICM
71
IronBridge Capital Management
Illinois
$5.24M +$755K +20,980 +19%
California State Teachers Retirement System (CalSTRS)
72
California State Teachers Retirement System (CalSTRS)
California
$5.07M +$233K +6,488 +5%
New York State Common Retirement Fund
73
New York State Common Retirement Fund
New York
$4.88M +$634K +17,628 +17%
SAM
74
Sectoral Asset Management
Quebec, Canada
$4.83M
Natixis Advisors
75
Natixis Advisors
Massachusetts
$4.79M +$318K +8,840 +8%

IART Hedge Fund Activity: Q2 2016 in Review

210 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q2 2016, worth a combined $2.67B — up 22% from $2.2B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new IART positions and 16 closed out — a net gain of 18 holders — while 80 added to existing stakes and 71 trimmed.

The largest buyer was RS Investment Management, opening a new position worth an estimated $51.1M. The largest seller was Victory Capital Management, exiting entirely with an estimated $22.1M sold.

  • 210 institutional investors held Integra LifeSciences (IART) as of Q2 2016, up from 194 in Q1 2016.
  • Funds reported $2.67B of Integra LifeSciences stock for Q2 2016, up 22% quarter-over-quarter.
  • 34 funds opened new Integra LifeSciences positions in Q2 2016 and 16 closed out, a net change of +18 holders.
  • The largest Integra LifeSciences buyer in Q2 2016 was RS Investment Management, an estimated $51.1M added.
  • The largest Integra LifeSciences seller in Q2 2016 was Victory Capital Management, an estimated $22.1M sold.

Based on aggregated 13F filings for Q2 2016.